Invention Grant
- Patent Title: Beta-lactamase inhibitors
-
Application No.: US14773717Application Date: 2014-03-13
-
Publication No.: US09944658B2Publication Date: 2018-04-17
- Inventor: Christopher J. Burns , Denis Daigle , Bin Liu , Daniel McGarry , Daniel C. Pevear , Robert E. Lee Trout
- Applicant: VenatoRx Pharmaceuticals, Inc.
- Applicant Address: US PA Malvern
- Assignee: VENATORX PHARMACEUTICALS, INC.
- Current Assignee: VENATORX PHARMACEUTICALS, INC.
- Current Assignee Address: US PA Malvern
- Agency: Wilson, Sonsini, Goodrich & Rosati
- International Application: PCT/US2014/026727 WO 20140313
- International Announcement: WO2014/151958 WO 20140925
- Main IPC: C07F5/02
- IPC: C07F5/02 ; A61K45/06 ; A61K31/69

Abstract:
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Public/Granted literature
- US20160024121A1 BETA-LACTAMASE INHIBITORS Public/Granted day:2016-01-28
Information query